Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 12, 2011 - Issue 10
Submit an article Journal homepage
289
Views
12
CrossRef citations to date
0
Altmetric
Editorial

Pioglitazone: a valuable component of combination therapy for type 2 diabetes mellitus

Nikolaos PapanasDemocritus University of Thrace, University Hospital of Alexandroupolis, Second Department of Internal Medicine, Outpatient Clinic of Obesity, Diabetes and Metabolism, 68100 Alexandroupolis, Greece+30 2551 084972; +30 2551 074723; [email protected]
,
Niki KatsikiUniversity College London (UCL), Royal Free Hospital Campus, University College London Medical School, Department of Clinical Biochemistry (Vascular Disease Prevention Clinics), London NW3 2QG, UK;Aristotle University of Thessaloniki, AHEPA University Hospital, First Propaedeutic Department of Internal Medicine, St. Kyriakidou 1, 54636, Thessaloniki, Greece
,
Apostolos I HatzitoliosAristotle University of Thessaloniki, AHEPA University Hospital, First Propaedeutic Department of Internal Medicine, St. Kyriakidou 1, 54636, Thessaloniki, Greece
&
Efstratios MaltezosDemocritus University of Thrace, University Hospital of Alexandroupolis, Second Department of Internal Medicine, Outpatient Clinic of Obesity, Diabetes and Metabolism, 68100 Alexandroupolis, Greece+30 2551 084972; +30 2551 074723; [email protected]
Pages 1457-1461 | Published online: 09 Jun 2011

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Niki Katsiki, Kyriakos Kazakos & Filippos Triposkiadis. (2022) Contemporary choice of glucose lowering agents in heart failure patients with type 2 diabetes. Expert Opinion on Pharmacotherapy 23:17, pages 1957-1974.
Read now

Articles from other publishers (11)

Y.A. El-Taravi, D. V. Baimukhambetova, C. L. Gorlenko, H. Yu. Kiseljow, I. Iu. Kokhanovskaia, A. I. Burotina, E. S. Rassadina, N. S. Martirosian & N. A. Petunina. (2023) Management of diabetes during Ramadan: an update for Russian-speaking doctors. Diabetes mellitus 26:1, pages 82-92.
Crossref
Niki Katsiki, Paschalis Steiropoulos, Nikolaos Papanas & Dimitri P. Mikhailidis. (2019) Diabetes Mellitus and Chronic Obstructive Pulmonary Disease: An Overview. Experimental and Clinical Endocrinology & Diabetes 129:10, pages 699-704.
Crossref
Camila Pires Mendes, Bárbara Graziela Postal, Marisa Jádna Silva Frederico, Rui Gonçalves Marques Elias, Veronica Aiceles de Medeiros Pinto, Cristiane da Fonte Ramos, Patrícia Devantier Neuenfeldt, Ricardo José Nunes & Fátima Regina Mena Barreto Silva. (2021) Synthesis of a novel glibenclamide-pioglitazone hybrid compound and its effects on glucose homeostasis in normal and insulin-resistant rats. Bioorganic Chemistry 114, pages 105157.
Crossref
A. E. Körei, I. Istenes, N. Papanas & P. Kempler. (2015) Small-Fiber Neuropathy. Angiology 67:1, pages 49-57.
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs 419 458 .
Kalliopi Pafili, Ioanna Gouni-Berthold, Nikolaos Papanas & Dimitri P. Mikhailidis. (2015) Abdominal aortic aneurysms and diabetes mellitus. Journal of Diabetes and its Complications 29:8, pages 1330-1336.
Crossref
Agnieszka Piwowar & Ewa _urawska-P_aksej. 2014. Role of Oxidative Stress in Chronic Diseases. Role of Oxidative Stress in Chronic Diseases 160 198 .
Cong Zou, Honglin Hu, Xiaoqing Xi, Zimin Shi, Gongxian Wang & Xueming Huang. (2013) Pioglitazone protects against renal ischemia-reperfusion injury by enhancing antioxidant capacity. Journal of Surgical Research 184:2, pages 1092-1095.
Crossref
Seda Suvag, Kristina M. Utzschneider & Steven E. Kahn. 2013. The Metabolic Syndrome. The Metabolic Syndrome 117 146 .
Honglin Hu, Cong Zou, Xiaoqing Xi, Ziming Shi, Gongxian Wang & Xueming Huang. (2012) Protective effects of pioglitazone on renal ischemia-reperfusion injury in mice. Journal of Surgical Research 178:1, pages 460-465.
Crossref
Yan Xing, Shandong Ye, Yuanyuan Hu & Yan Chen. (2012) Podocyte as A Potential Target of Inflammation: Role of Pioglitazone Hydrochloride in Patients With Type 2 Diabetes. Endocrine Practice 18:4, pages 493-498.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.